{"result": "(\"entity\"<|>ABBOTT<|>ORGANIZATION<|>Abbott is a healthcare company that produces nutritional products, including various enteral formulas for medical use.)\n##\n(\"entity\"<|>FRESENIUS KABI<|>ORGANIZATION<|>Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies, including enteral nutrition products.)\n##\n(\"entity\"<|>NESTLÉ<|>ORGANIZATION<|>Nestlé is a multinational food and beverage company known for its nutritional products, including enteral formulas.)\n##\n(\"entity\"<|>GRIFOLS<|>ORGANIZATION<|>Grifols is a global healthcare company that produces plasma-derived medicines and nutritional products, including enteral formulas.)\n##\n(\"entity\"<|>NUTRICIA<|>ORGANIZATION<|>Nutricia is a specialized nutrition company that provides medical nutrition products, including enteral formulas for patients.)\n##\n(\"entity\"<|>GLUCERNA 1,2<|>EVENT<|>Glucerna 1,2 is a nutritional product designed for people with diabetes, providing a specific caloric and nutrient profile.)\n##\n(\"entity\"<|>DIBEN 1,5 KCAL HP<|>EVENT<|>Diben 1,5 kcal HP is a high-protein enteral formula designed for patients requiring additional protein intake.)\n##\n(\"entity\"<|>NOVASOURCE PEPTIDE PLUS<|>EVENT<|>Novasource Peptide Plus is an enteral formula designed for patients with specific dietary needs, providing a balanced nutrient profile.)\n##\n(\"entity\"<|>NUTRISON ADVANCED PEPTISORB<|>EVENT<|>Nutrison Advanced Peptisorb is an enteral formula designed for patients with malabsorption issues, providing easily digestible nutrients.)\n##\n(\"entity\"<|>ALITRAQ<|>EVENT<|>Alitraq is an enteral formula designed for patients requiring specialized nutrition, often used in clinical settings.)\n##\n(\"relationship\"<|>ABBOTT<|>GLUCERNA 1,2<|>Abbott produces Glucerna 1,2, a nutritional product for people with diabetes<|>8)\n##\n(\"relationship\"<|>FRESENIUS KABI<|>DIBEN 1,5 KCAL HP<|>Fresenius Kabi produces Diben 1,5 kcal HP, a high-protein enteral formula<|>8)\n##\n(\"relationship\"<|>NESTLÉ<|>NOVASOURCE PEPTIDE PLUS<|>Nestlé produces Novasource Peptide Plus, an enteral formula for specific dietary needs<|>8)\n##\n(\"relationship\"<|>GRIFOLS<|>NUTRISON ADVANCED PEPTISORB<|>Grifols produces Nutrison Advanced Peptisorb, designed for patients with malabsorption<|>8)\n##\n(\"relationship\"<|>NUTRICIA<|>ALITRAQ<|>Nutricia produces Alitraq, a specialized enteral formula for clinical nutrition<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 1,5 | Abbott | 1,5 | Pack 1000 ml, Vainilla | 487 | 45 g (18%) Hidrolizado de Lactoalbúmina | 122 (49%) Maltodextrina Sacarosa | 36,6 (33%) 70% MCT | 1126 1333 | 0 |\n| OLIGOMÉRICAS | Survimed OPD HN | Fresenius Kabi | 1,33 | EasyBag 500 ml Neutro | 370 | 50,4 (20%) Suero lácteo hidrolizado | 137,6 (55%) Dextrinomaltosa | 27,8 (25%) Colza, Girasol, 52% MCT, 21% Mono, DHA + EPA; ω6/ω3 = 3,6 | 1000 1950 | 0 |\n| OLIGOMÉRICAS | Novasource Peptide Plus | Nestlé | 1,52 | Smartflex 500 ml Neutro | 380 | 61,8 (25%) Suero de leche hidrolizada | 92,1 (37%) Maltodextrina, Almidón | 42,7 (38%) 58% MCT, 22% Soja, 20% Pescado | 650 1500 | 0 |\n| OLIGOMÉRICAS | Survimed OPD | Fresenius Kabi | 1 | EasyBag 500 ml Neutro | 300 | 45 (18%) Suero de leche hidrolizado | 143 (57%) Dextrinomaltosa | 28 (25%) Colza, Girasol, Pescado 51% MCT, 22% Mono, EPA + DHA; ω6/ω3 = 3,5 | 800 2000 | 0 |\n| OLIGOMÉRICAS | Dietgriff polipeptídico | Grifols | 1 | Botella 500 ml Neutro | 350 | 45 (18%) Hidrolizado de Lactoalbúmina, Soja | 190 (75%) Maltodextrina | 7,5 (7%) Girasol, 23% Mono | 1150 1550 | 0 |\n| OLIGOMÉRICAS | Novasource Peptide | Nestlé | 1 | Smartflex 500 ml Neutro | 200 | 40 (16%) Suero de leche hidrolizada | 127 (51%) Maltodextrina, Almidón, Jarabe glucosa | 37 (33%) 82% MCT, 18% Soja | 740 500 | 0 |\n| OLIGOMÉRICAS | Nutrison Advanced Peptisorb | Nutricia | 1 | Botella 500 ml/ 1000 ml Neutro | 455 | 40 (16%) Lactoproteína hidrolizada | 176 (69%) Polisacáridos | 17 (15%) 47% MCT ω6/ω3 = 10,9 | 1000 1500 | 0 |\n| OLIGOMÉRICAS | Alitraq | Abbott | 1 | Sobres 76 g x 24 uds. | 480 | 52,7 (20%) Hidrolizado de lactoalbúmina, Soja | 164 (65%) Maltodextrina Sacarosa, Fructosa | 15 (14%) 55% MCT 44% Poliinsaturados | 1000 1000 | 0 |\n---\nAnexo 5. Fórmulas enterales para infusión por sonda más empleadas en nuestro medio\n\n| Grupo | Producto® | Empresa | Kcal/ ml | Presentación | Osmol | Proteínas g/1000 kcal (%) | Hidratos de carbono g/1000 kcal (%) | Lípidos g/1000 kcal (%) | Sodio Potasio mg/1000 kcal | Otros g Fibra/1000 kcal (sol/insol) Caract. espec. |\n|-------|-----------|----------|----------|--------------|-------|---------------------------|-------------------------------------|------------------------|----------------------------|--------------------------------------------------|\n| DIABETES HIPERCALÓRICAS | Glucerna 1,2 | Abbott | 1,2 | Botella 500 ml Vainilla | 585 | 50 (20%) Caseína, Soja | 84 (35%) DXM, Isomaltulosa, Glicerina, Fructosa, Sucromalt, Fibersol | 50 (45%) | 900 1550 | 14,2 (70/30) FOS |\n| | Diben 1,5 kcal HP | Fresenius Kabi | 1,5 | EasyBag 500 ml Neutro | 450 | 50 (20%) Leche | 87,3 (35%) DXM, Dextrina de tapioca, Isomaltulosa, Fructosa | 46,6 (42%) Colza, Girasol, Soja, 17% MCT, 52% Mono, DHA + EPA; ω6/ω3 = 2,4 | 350 1200 | 15,3 (78/22) (3%) Dextrina de tapioca, Celulosa, Inulina |\n| | Novasource Di\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}